Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial—Clinical outcomes and molecular determinants of response.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Murphy, Caitlin1,2; Muscat, Andrea2; Ashley, David1,2,3; Mukaro, Violet1,2; West, Linda1,4; Liao, Yang5; Chisanga, David5; Shi, Wei5; Collins, Ian2,6; Baron-Hay, Sally7,8; Patil, Sujata9; Lindeman, Geoffrey5; Khasraw, Mustafa1,2,10
- المصدر:
PLoS ONE. 2/14/2019, Vol. 14 Issue 2, p1-20. 20p.
No Comments.